Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)

Introduction Multiple myeloma (MM) patients have an increased risk of severe coronavirus disease 2019 (COVID-19) when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Monoclonal gammopathy of undetermined significance (MGUS) precedes MM and related disorders and affects 4....

Full description

Bibliographic Details
Main Authors: Rögnvaldsson, Sæmundur, Eythorsson, Elias, Thorsteinsdottir, Sigrun, Vidarsson, Brynjar, Onundarson, Pall Torfi, Agnarsson, Bjarni Agnar, Sigurdardottir, Margret, Thorsteinsdottir, Ingunn, Olafsson, Isleifur, Runolfsdottir, Hrafnhildur Linnet, Helgason, Dadi, Emilsdóttir, Arna, Bjornsson, Aron H, Kristjansdottir, Gudrun, Thordardottir, Asdis Rosa, Indridason, Olafur Skuli, Jonsson, Asbjorn, Gislason, Gauti Kjartan, Olafsson, Andri, Steingrimsdottir, Hlif, Kampanis, Petros, Hultcrantz, Malin, Durie, Brian G.M., Harding, Stephen, Landgren, Ola, Love, Thorvardur Jon, Palsson, Runolfur, Kristinsson, Sigurdur Y
Format: Online Article Text
Language:English
Published: American Society of Hematology. Published by Elsevier Inc. 2021
Subjects:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701832/
http://dx.doi.org/10.1182/blood-2021-153145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701832/
http://dx.doi.org/10.1182/blood-2021-153145

Similar Items